03:35:32 EDT Sun 05 May 2024
Enter Symbol
or Name
USA
CA



Q:EVGN - EVOGENE LTD - Website unknown - click to update
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
EVGN - Q0.30.6867·0.760.80.7125.4121000.70  0.7315  0.67061.44  0.450216:28:38Apr 1615 min RT 2¢

Recent Trades - Last 10 of 100
Time ETExPriceChangeVolume
16:28:38Q0.73160.0261500
16:00:01Q0.710.00451
16:00:01Q0.710.00451
16:00:01Q0.710.00457
16:00:00Q0.710.00451
15:59:14Q0.71 1,477
15:59:03Q0.710.004517
15:59:02Q0.710.00453
15:59:00Q0.70990.00443
15:59:00Q0.70990.004497

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2024-04-16 07:00U:EVGNNews ReleaseBiomica to Present at the American Society of Clinical Oncology (ASCO) 2024 Annual Meeting
2024-04-11 07:00U:EVGNNews ReleaseBiomica to Present at Digestive Disease Week (DDW) Conference 2024 Annual Meeting
2024-04-02 07:00U:EVGNNews ReleaseEvogene and The Kitchen FoodTech Hub by Strauss Group Established Finally Foods Ltd. - Revolutionizing Protein Production in Plants for the Food Industry
2024-03-28 09:00U:EVGNNews ReleaseEvogene Announces Filing of Annual Report on Form 20-F
2024-03-20 09:00U:EVGNNews ReleaseEvogene Reports Receipt of Nasdaq Minimum Bid Price Notification
2024-03-19 09:00U:EVGNNews ReleaseBayer AG and Lavie Bio Continue for Second Year of Biofungicides Validation Following Successful Lab and Greenhouse Testing
2024-03-13 09:00U:EVGNNews ReleaseLavie Bio and Ceres Global Ag Corp. Collaborate to Include YalosTM Bio-Inoculant, in Regenerative Agriculture Initiatives in North America
2024-03-07 07:00U:EVGNNews ReleaseEvogene Reports Fourth Quarter and Full Year 2023 Financial Results
2024-03-06 07:00U:EVGNNews ReleaseAgPlenus Achieves Milestone in Collaboration with Corteva to Develop Novel Herbicides
2024-03-05 07:00U:EVGNNews ReleaseCasterra Announces New Agreements with Seed Producers in Brazil and Africa to Meet Growing Demand for its Elite Castor Seed Varieties
2024-02-28 07:00U:EVGNNews ReleaseLavie Bio Successfully Secures Second Half Advance Payment of $2.5M after Meeting Corteva's Licensing Agreement Requirements
2024-02-26 07:00U:EVGNNews ReleaseEvogene Schedules Fourth Quarter 2023 Financial Results Release & Conference Call for March 7th, 2024
2024-02-22 07:00U:EVGNNews ReleaseAgPlenus Announces Appointment of Dr. Dan Jacob Gelvan as its Incoming Chief Executive Officer
2024-02-21 07:00U:EVGNNews ReleaseAgPlenus Announces Licensing & Collaboration Agreement with Bayer to Develop a New Sustainable Weed Control Solution
2024-02-20 07:00U:EVGNNews ReleaseSyngenta and Lavie Bio Announce Partnership to Discover and Develop Novel Bio-Insecticide
2024-02-06 07:08U:EVGNNews ReleaseEvogene and Verb Biotics Enter Collaboration Agreement to Advance Probiotic Innovation
2024-01-23 07:00U:EVGNNews ReleaseBiomica CEO Set to Engage in Panel Discussion at 8th Annual European Microbiome Movement Summit
2024-01-17 07:00U:EVGNNews ReleaseBiomica Successfully Completes Phase I Trial Enrollment for Microbiome-Based Immuno-Oncology Drug
2023-12-21 07:00U:EVGNNews ReleaseBiomica CEO Set to Attend JP Morgan Healthcare Week in San Francisco, January 8-11, 2024
2023-12-19 07:00U:EVGNNews ReleaseCasterra Appoints New CEO and Expands Team to Drive Growth and Innovation